Mylan and Pfizer are fighting a lawsuit alleging the companies engaged in a vast, illegal scheme to boost sales for EpiPen. But plaintiffs say Mylan “surreptitiously” reached out to vendors and forced them not to release certain documents.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,